Cytel, officially known as Cytel Inc., is a leading provider of advanced statistical software and services, headquartered in the United States. Founded in 1981, the company has established a strong presence in the biostatistics and clinical trial sectors, with major operational regions across North America, Europe, and Asia. Cytel is renowned for its innovative solutions in clinical development, particularly its software products like East and StatXact, which streamline the design and analysis of clinical trials. These offerings are distinguished by their robust statistical methodologies and user-friendly interfaces, catering to the needs of pharmaceutical and biotechnology companies. With a commitment to enhancing the efficiency of clinical research, Cytel has achieved significant milestones, including partnerships with leading global organisations. Its reputation as a trusted partner in the industry underscores its market position and dedication to advancing healthcare through data-driven insights.
How does Cytel's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cytel's score of 39 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Cytel Inc. reported total greenhouse gas emissions of approximately 7,126,650 kg CO2e, with emissions distributed across various scopes: 3,570 kg CO2e from Scope 1, 47,270 kg CO2e from Scope 2 (market-based), and a significant 7,121,010 kg CO2e from Scope 3. The Scope 3 emissions included major contributions from purchased goods and services (4,863,000 kg CO2e), business travel (896,300 kg CO2e), and employee commuting (1,072,700 kg CO2e). Cytel has set ambitious reduction targets through the Science Based Targets initiative (SBTi). The company commits to reducing its absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the base year. Additionally, Cytel aims to decrease its Scope 3 emissions by 51.6% per million USD value added within the same timeframe. These targets align with the necessary reductions to limit global warming to 1.5°C, demonstrating Cytel's commitment to addressing climate change effectively. Overall, Cytel's emissions data reflects a comprehensive approach to sustainability, with a clear focus on reducing its carbon footprint across all scopes of emissions.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 63,400  | 00,000  | 0,000  | 
| Scope 2 | 95,600  | 000,000  | 00,000  | 
| Scope 3 | 1,814,220  | 0,000,000  | 0,000,000  | 
Cytel's Scope 3 emissions, which increased by 13% last year and increased by approximately 293% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 68% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cytel has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Cytel's sustainability data and climate commitments